Anne Wojcicki, a co-founder and former CEO of 23andMe, is regaining control of the company by acquiring substantially all of its assets through a nonprofit organization. This move aims to reposition 23andMe under Wojcicki’s leadership while maintaining a focus on genetic research and consumer health initiatives. The transition underscores Wojcicki’s commitment to advancing the company’s mission in a rapidly evolving healthcare landscape.
— new from The Verge
